Law360, New York (January 9, 2012, 1:38 PM EST) -- In December 2011, the U.S. Food and Drug Administration (FDA) for the first time issued warning letters to marketers of gastric weight-loss band devices in California. The FDA is concerned that the companies' ads violate federal regulations by potentially downplaying the risks and complications of specific weight-reduction surgeries.
Regulators in California's Department of Insurance, likely among other state regulators, took notice of the FDA's warning letters. The fact is, California consumer enforcement actions appear to be on the rise in recent years.
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.